Neomorph
San Diego
About Neomorph
Neomorph is building a leading protein degradation entity, focused on “molecular glue” degraders. Its mission is to use this technology to solve critical problems in human health with the discovery and development of innovative new medicines against “undruggable targets.”
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $109.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2020)
- Website: neomorph.com
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/neomorph-52792 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.